Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Cardiac Sciences Guidelines
    • India Antibiotic...

    India Antibiotic Guideline For Post Cardiovascular Surgery Infections

    Written by supriya kashyap kashyap Published On 2016-09-19T15:35:07+05:30  |  Updated On 19 Sept 2016 3:35 PM IST
    India Antibiotic Guideline For Post Cardiovascular Surgery Infections

    In 2016, National Centre For Disease Control, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India came out with National Treatment Guidelines for Antimicrobial Use in Infectious Diseases.



    Following are major recommendations


    Post-Cardiovascular Surgery Infections :


    Surveillance regarding the Infections following CTVS should be done in each institute


    1. Antibiotic Prophylaxis to be guided by the institutional prevalence of MRSA infection and in patients at increased risk for MRSA colonization


    2. Nasal screening before CTV surgery is recommended to rule out MRSA colonization













    S. no.Surgery Antibiotic ProphylaxisComments














    1 st line2 nd lineSpecial Antibiotic/Combination















    1.

    CABG

    Cefazolin

    Cefuroxime

    -Vancomycin /Teicoplanin to be used in case of high prevalence of MRSA infections only Using only

    Vancomycin/Teicoplanin is NOT recommended due to lack of coverage of GNB

    Vancomycin infusion to be given over 1 hour & to be started 2 hrs before the surgical incision

    Teicoplanin dosing to start with 800 mg x 3 doses and then 6 mg/kg to complete prophylxis Duration of Prophylaxis: Continued till 48 hours after the surgery

    Empirical Treatment after appropriate specimen for stain & cultures have been collected














    S. noInfection/ SyndromeLikely Causative agents AntibioticsComments





























































    1 st line2 nd lineSpecial Antibiotic/ Combination
    1Sternotomy site infection Not knownBL-BLI (Piperacillin-tazobactam, Cefoperazone-sulbactam, cefipime-tazobactam) with or without amikacin. With Vancomycin/ teicoplaninDaptomycin/ Linezolid

    with carbapenem
    Consider deescalation to TMP/SMX , doxy/minocycline, cloxacillin, cefazolin, If these are sensitive1) Removal of the foreign body (steel wires) should be considered
    2Infection of vascular catheters Not knownBL-BLI (Piperacillin-tazobactam, Cefoperazone-sulbactam, cefipime-tazobactam) with or without amikacin with Vancomycin/ teicoplaninCarbapenem

    (Empirical anti-MRSA drug if the incidence of MRSA CRBSI is high)
    Consider de-escalation as per the isolate, susceptibility, MICs, adverse effects, drug allergy
    3Pneumonia Not knownBL-BLI (Piperacillin-tazobactam, Cefoperazone-sulbactam) with or without amikacinCarbapenemConsider de-escalation as per the isolate, susceptibility, MICs, adverse effects, drug allergy
    4MediastinitisNot knownBL-BLI (Piperacillin-tazobactam, Cefoperazone-sulbactam) with or without amikacin With Vancomycin/ teicoplaninCarbapenem with or without AmikacinConsider de-escalation as per the isolate,
    5Urinary tract infection Not knownBL-BLI (Piperacillin-tazobactam, Cefoperazone-sulbactam with or without amikacinCarbapenem with or without AmikacinConsider de-escalation as per the isolate, susceptibility, MICs, adverse effects, drug allergy


    Definitive Treatment after appropriate specimen for stain & cultures have been collected














    S. noInfection/ SyndromeLikely Causative agents AntibioticsComments
















    1Sternotomy site infection Coagulase Negative Staphylococc iVancomycin, TeicoplaninDaptomycin LinezolidConsider de-escalation to Cotrimoxazole or Cloxacillin or Cefazolin

    Consider de-escalation to TMP/SMX or doxy/minocycline If these are sensitive
    1) Consider MICs, risk of nephrotoxicity , bone penetration

    for choosing the antibiotic 2) Removal of


    Directorate General of health servicesGovernment of IndiaInfectious diseasesMinistry of Health & Family WelfarePost-Cardiovascular Surgery Infections

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok